Session 1: Which process and analytical tools have the requisite flexibility, scalability, and cost-effectiveness to enable rapid clinical translation while laying the groundwork for later development and commercialisation? Part 1

Advanced Therapies Week 2027 · 19 January 2027 · 11:00–12:00 · Theatre 1

Session 1: Which process and analytical tools have the requisite flexibility, scalability, and cost-effectiveness to enable rapid clinical translation while laying the groundwork for later development and commercialisation? Part 1 was a session at Advanced Therapies Week 2027 on 19 January 2027 in San Diego, with 4 speakers on record.

Speakers

• Vasily Medvedev — Speaker Chief Technology Officer, VVMF
• Ohad Karnieli — Speaker Adva Biotechnology
• Meena Narayanan — Speaker Senior Scientist - Process Analytics, Genentech
• Nelly Viseux — Speaker VP Cell Therapies Development, Manufacturing Supply & Quality, Regeneron Pharmaceuticals